Mitochondrial Structural Abnormalities and Cardiac Reverse Remodeling in Patients With Systolic Dysfunction
Koji Nakano1, Masayoshi Yamamoto1, Yu Yamada1
1Department of Cardiology, Institute of Medicine, University of Tsukuba.
Summary
Mitochondrial cristae disorganization in heart failure patients is linked to worse outcomes and reverse remodeling. This finding may influence heart failure management strategies.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Pathology
Background:
- Mitochondrial dysfunction is implicated in heart failure (HF).
- The clinical impact of structural mitochondrial abnormalities in HF patients is not well understood.
Purpose of the Study:
- To investigate the association between mitochondrial structural abnormalities and clinical outcomes in patients with left ventricular (LV) systolic dysfunction.
Main Methods:
- Electron microscopy was used to analyze mitochondrial structure (size, outer membrane, cristae) in myocardial specimens from 91 patients with LV systolic dysfunction.
- Patients were categorized based on LV reverse remodeling (LVRR) status.
- Clinical outcomes, including cardiovascular death and HF hospitalization, were tracked for one year post-biopsy.
Main Results:
- Cristae disorganization was found in 23.1% of patients and was significantly more common in the LVRR-negative group (38.5%) compared to the LVRR-positive group (11.5%).
- Cristae disorganization was independently associated with a composite endpoint of cardiovascular death and HF hospitalization (P=0.002).
- This association remained significant even after adjusting for factors like age, blood pressure, B-type natriuretic peptide, and mitral regurgitation.
Conclusions:
- Mitochondrial cristae disorganization is a structural abnormality associated with both LV reverse remodeling and a poorer prognosis in patients with systolic dysfunction.
- These findings suggest that mitochondrial structural assessment, particularly cristae integrity, could be valuable in managing HF patients.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
01:29Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
2
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
01:25Cardiomyopathy I: Introduction and Classification
2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K